DANVATIRSEN

Investigational

Approval Year

Show entries

Name

Type

Language

DANVATIRSEN

Official Name

English

ALL-P-AMBO-2'-O,4'-C-((1S)-ETHANE-1,1-DIYL)-5-METHYL-PTHIOCYTIDYLYL-(3'->5')-2'-O,4'-C-((1S)-ETHANE-1,1-DIYL)-5-METHYL-P-THIOURIDYLYL-(3'->5')-2'-O,4'-C-((1S)-ETHANE-1,1-DIYL)-P-THIOADENYLYL-(3'->5')-P-THIOTHYMIDYLYL-(3'->5')-PTHIOTHYMIDYLYL-(3'->5')-P-T

Common Name

English

danvatirsen [INN]

Common Name

English

ISIS-481464

Code

English

Danvatirsen [WHO-DD]

Common Name

English

Showing 1 to 5 of 11 entries

Previous1 2 3Next

Show entries

Classification Tree

Code System

Code

Gene Therapy Agent

NCI_THESAURUS

C1291

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

CAS

1402357-06-5

PRIMARY

INN

10612

PRIMARY

FDA UNII

31N550RD05

PRIMARY

DRUG BANK

DB14825

PRIMARY

USAN

FG-83

PRIMARY

Showing 1 to 5 of 7 entries

Previous1 2Next

Subunit 0

Show entries

Sugar	Site Range	Site Count
Deoxyribose (DNA)	1_4-1_13	10 / 16
2,'4'-locked-Ribose (alpha-L-LNA)	1_1-1_3;1_14-1_16	6 / 16

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Linkage	Site Range	Site Count
Phosporothioate	1_2-1_16	15 / 15

Showing 1 to 1 of 1 entries

Previous1Next

ACTIVE MOIETY


					31N550RD05

DANVATIRSEN

SALT/SOLVATE (PARENT)


					S6A2UYH57V

DANVATIRSEN SODIUM